Drugs / Apornemin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06793475 | Apr 2025 → Jun 2026 overdue | plasma cell myeloma | Institute of Hematology & Blood Diseases Hospital, China | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Apornemin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06793475 ↗ |
| Route | Intravenous | “Apornemin 10mg/kg will be administered by i.v. infusion.” NCT06793475 ↗ |